albuterol has been researched along with Pulmonary Alveolar Proteinosis in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Pulmonary Alveolar Proteinosis: A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Key Words: Pulmonary alveolar proteinosis, Child, Atopy, Wheezing." | 1.72 | First Documented Case of Pulmonary Alveolar Proteinosis with Atopy Presenting Secondary to CSFR2B Mutation. ( Avci, A; Kiyan, G; Ozcan, D; Sasihuseyinoglu, AS, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasihuseyinoglu, AS | 1 |
| Ozcan, D | 1 |
| Avci, A | 1 |
| Kiyan, G | 1 |
1 other study available for albuterol and Pulmonary Alveolar Proteinosis
| Article | Year |
|---|---|
First Documented Case of Pulmonary Alveolar Proteinosis with Atopy Presenting Secondary to CSFR2B Mutation.
Topics: Albuterol; Bronchoalveolar Lavage; Child; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; | 2022 |